Manna Eliza Del Fiol, Serrano Davide, Cazzaniga Laura, Mannucci Sara, Zanzottera Cristina, Fava Francesca, Aurilio Gaetano, Guerrieri-Gonzaga Aliana, Risti Matilde, Calvello Mariarosaria, Feroce Irene, Marabelli Monica, Altemura Cecilia, Bertario Lucio, Bonanni Bernardo, Lazzeroni Matteo
Division of Oncogenetics, Unimed Sorocaba, Sorocaba 18040-580, Brazil.
Division of Cancer Prevention and Genetics, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
Genes (Basel). 2025 Jan 13;16(1):82. doi: 10.3390/genes16010082.
Women carrying pathogenic/likely pathogenic (P/LP) variants in moderate- or high-penetrance genes have an increased risk of developing breast cancer. However, most P/LP variants associated with breast cancer risk show incomplete penetrance. Age, gender, family history, polygenic risk, lifestyle, reproductive, hormonal, and environmental factors can affect the expressivity and penetrance of the disease. However, there are gaps in translating how individual genomic variation affects phenotypic presentation. The expansion of criteria for genetic testing and the increasing utilization of comprehensive genetic panels may enhance the identification of individuals carrying P/LP variants linked to hereditary breast cancer. Individualized risk assessment could facilitate the implementation of personalized risk-reduction strategies for these individuals. Preventive interventions encompass lifestyle modifications, chemoprevention, enhanced surveillance through breast imaging, and risk-reducing surgeries. This review addresses the current literature's inconsistencies and limitations, particularly regarding risk factors and the intensity of preventive strategies for women with P/LP variants in moderate- and high-penetrance genes. In addition, it synthesizes the latest evidence on risk assessment and primary and secondary prevention in women at high risk of breast cancer.
携带中高外显率基因致病性/可能致病性(P/LP)变异的女性患乳腺癌的风险增加。然而,大多数与乳腺癌风险相关的P/LP变异表现出不完全外显。年龄、性别、家族史、多基因风险、生活方式、生殖、激素和环境因素会影响该疾病的表现度和外显率。然而,在将个体基因组变异如何影响表型表现转化为实际应用方面仍存在差距。基因检测标准的扩大以及综合基因检测板使用的增加,可能会提高对携带与遗传性乳腺癌相关的P/LP变异个体的识别。个性化风险评估有助于为这些个体实施个性化的风险降低策略。预防性干预措施包括生活方式改变、化学预防、通过乳房成像加强监测以及降低风险的手术。本综述阐述了当前文献中的不一致之处和局限性,特别是关于携带中高外显率基因P/LP变异女性的风险因素和预防策略强度方面。此外,它还综合了乳腺癌高危女性风险评估以及一级和二级预防的最新证据。